Published in Environ Health Perspect on October 01, 1993
Assessing human germ-cell mutagenesis in the Postgenome Era: a celebration of the legacy of William Lawson (Bill) Russell. Environ Mol Mutagen (2007) 1.20
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet (1984) 2.84
Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 2.65
Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J Invest Dermatol (1990) 2.31
Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc Natl Acad Sci U S A (1989) 2.22
In vivo somatic mutations in humans: measurement and analysis. Annu Rev Genet (1990) 1.83
Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet (1991) 1.59
Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature (1985) 1.52
T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci U S A (1982) 1.45
Measurement of in vivo mutations in human lymphocytes. Nature (1983) 1.41
A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat Res (1988) 1.38
Bloom's syndrome: evidence for an increased mutation frequency in vivo. Science (1983) 1.34
Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science (1987) 1.27
Structural organization of glycophorin A and B genes: glycophorin B gene evolved by homologous recombination at Alu repeat sequences. Proc Natl Acad Sci U S A (1989) 1.19
Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum Genet (1986) 1.18
Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients. Hum Genet (1990) 1.16
Inheritance of purine phosphoribosyltransferases in man. Am J Hum Genet (1969) 1.15
DNA sequence analysis of in vivo hprt mutation in human T lymphocytes. Mutagenesis (1990) 1.12
Biological and chemical monitoring of occupational exposure to ethylene oxide. Mutat Res (1991) 1.12
Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res (1989) 1.10
Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study. Mutat Res (1988) 1.07
An improved flow cytometric assay for somatic mutations at the glycophorin A locus in humans. Cytometry (1990) 1.07
Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo. Mutat Res (1979) 1.06
Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am J Hum Genet (1989) 1.05
Mutation frequency in human lymphocytes increases with age. Mech Ageing Dev (1984) 1.05
Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cels. Proc Natl Acad Sci U S A (1988) 1.01
Structural analysis of a membrane glycoprotein: glycophorin A. J Supramol Struct (1977) 1.00
Molecular nature of in vivo mutations in human cells at the autosomal HLA-A locus. Cancer Res (1990) 0.98
Increased somatic cell mutant frequency in atomic bomb survivors. Mutat Res (1988) 0.97
The effect of chemotherapy on the in vivo frequency of glycophorin A 'null' variant erythrocytes. Mutat Res (1990) 0.97
A cytogenetic follow-up study of the victims of a radiation accident in Goiania (Brazil). Mutat Res (1991) 0.93
Mutations affecting RNA splicing in man are detected more frequently in somatic than in germ cells. Mutat Res (1990) 0.92
Comparison of hprt variant frequencies and chromosome aberration frequencies in lymphocytes from radiotherapy and chemotherapy patients: a prospective study. Environ Mol Mutagen (1991) 0.92
Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns. Environ Mol Mutagen (1989) 0.91
In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes. Mutat Res (1991) 0.90
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis (1990) 0.90
Mutations in human lymphocytes studied by an HLA selection system. Mutat Res (1988) 0.90
Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo. Environ Mol Mutagen (1988) 0.89
Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26). Am J Hum Genet (1991) 0.89
Novel biodosimetry methods applied to victims of the Goiânia accident. Health Phys (1991) 0.89
In vivo hprt mutant frequencies in T-cells of normal human newborns. Mutat Res (1990) 0.89
In vivo mutant frequency rises among breast cancer patients after exposure to high doses of gamma-radiation. Mutat Res (1985) 0.88
Increased mutation frequency following treatment with cancer chemotherapy. Cancer Res (1985) 0.87
Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT) Mutagenesis (1990) 0.87
Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production. Mutat Res (1990) 0.87
Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes. Mutat Res (1988) 0.86
6-Thioguanine-resistant T-lymphocyte autoradiographic assay. Determination of variation frequencies in individuals suspected of radiation exposure. Mutat Res (1990) 0.85
In vivo mutant frequency of technicians professionally exposed to ionizing radiation. Prog Clin Biol Res (1986) 0.84
Mutant frequency of radiotherapy technicians appears to be associated with recent dose of ionizing radiation. Health Phys (1989) 0.83
Detection of somatic mutants in man: HPRT mutations in lymphocytes and hemoglobin mutations in erythrocytes. Mutat Res (1989) 0.82
The HLA-A mutation assay: improved technique and normal results. Mutat Res (1989) 0.82
Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat Res (1986) 0.82
The use of bromodeoxyuridine labeling in the human lymphocyte HGPRT somatic mutation assay. Mutat Res (1987) 0.81
Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer. Cancer Res (1991) 0.81
Exposure of nuclear medicine patients to ionizing radiation is associated with rises in HPRT- mutant frequency in peripheral T-lymphocytes. Mutat Res (1987) 0.80
Goiania radiation accident: results of initial dose estimation and follow up studies. Prog Clin Biol Res (1991) 0.79
Spontaneous 6-thioguanine-resistant lymphocytes in Fanconi anemia patients and their heterozygous parents. Hum Genet (1985) 0.77
Analysis of human HPRT deletion mutations with X-linked probes and pulsed field gel electrophoresis. Environ Mol Mutagen (1991) 0.77
Radionuclide angiography with technetium-99m in vivo labeled erythrocytes does not lead to induction of mutations in the HPRT gene of human T-lymphocytes. J Nucl Med (1991) 0.76
In vivo mutant T cell frequency in atomic bomb survivors carrying outlying values of chromosome aberration frequencies. Mutat Res (1988) 0.76
T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (1990) 2.77
Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots. Mutagenesis (1987) 2.33
The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res (2000) 2.01
Two forms of biosynthetic acetohydroxy acid synthetase in Salmonella typhimurium. Biochem Biophys Res Commun (1972) 1.94
In vivo somatic mutations in humans: measurement and analysis. Annu Rev Genet (1990) 1.83
Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis (2006) 1.64
Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med (1998) 1.58
Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature (1985) 1.52
High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination. Cancer Res (1997) 1.48
Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. Mutat Res (1998) 1.42
Lupus prone (SWR x NZB)F1 mice produce potentially nephritogenic autoantibodies inherited from the normal SWR parent. J Immunol (1985) 1.37
Temperature-sensitive growth inhibition by valine in Salmonella typhimurium: alteration of one form of acetohydroxy acid synthetase. J Bacteriol (1973) 1.33
Treatment of intertrochanteric fracture of the femur using sliding screw plate fixation. Clin Orthop Relat Res (1982) 1.32
Mitochondrial genome damage associated with cigarette smoking. Cancer Res (1996) 1.27
A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system. Mutat Res (1977) 1.25
The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids (2004) 1.14
V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res (1991) 1.14
Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis (1987) 1.14
DNA sequence analysis of in vivo hprt mutation in human T lymphocytes. Mutagenesis (1990) 1.12
Chemical mutagenesis of mammalian cells can be quantified. Nature (1977) 1.11
Thymic epithelial genotype influences the production of recombinant leukemogenic retroviruses in mice. J Virol (1983) 1.08
Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis (1994) 1.05
Possible role of adenosine cyclic 3':5'-monophosphate phosphodiesterase in the morphological transformation of Chinese hamster ovary cells mediated by N6,O2-dibutyryl adenosine cyclic 3':5"-monophosphate. J Biol Chem (1975) 1.04
Southern analysis of DNA polymorphism among Dw subtypes of DR4. Hum Immunol (1985) 1.00
Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact (2001) 0.98
Effect of cyclopentaneglycine on metabolism in Salmonella typhimurium. J Bacteriol (1972) 0.98
The use of Chinese hamster ovary cells to quantify specific locus mutation and to determine mutagenicity of chemicals. A report of the gene-tox program. Mutat Res (1981) 0.94
Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease. Mutat Res (2001) 0.94
The effect of folate deficiency on the hprt mutational spectrum in Chinese hamster ovary cells treated with monofunctional alkylating agents. Mutat Res (1999) 0.92
Factors influencing mutation at the hprt locus in T-lymphocytes: studies in normal women and women with benign and malignant breast masses. Environ Mol Mutagen (1992) 0.91
Quantitative analyses of radiation- and chemical-induced lethality and mutagenesis in Chinese hamster ovary cells. Radiat Res (1978) 0.91
Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in thirteen Spanish families. Hum Mutat (2000) 0.91
Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns. Environ Mol Mutagen (1989) 0.91
Molecular analyses of in vivo hprt mutations in human T-lymphocytes. III. Longitudinal study of hprt gene structural alterations and T-cell clonal origins. Mutat Res (1989) 0.91
In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytes. Mutat Res (1991) 0.90
Genotoxic markers among butadiene polymer workers in China. Carcinogenesis (2000) 0.90
Phenotypic expression time of mutagen-induced 6-thioguanine resistance in Chinese hamster ovary cells (CHO/HGPRT system). Mutat Res (1979) 0.90
Correlation between changes in intracellular level of cyclic AMP, activation of cyclic AMP-dependent protein kinase, and the morphology of Chinese hamster ovary cells in culture. Arch Biochem Biophys (1977) 0.90
Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo. Environ Mol Mutagen (1988) 0.89
Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures. Somat Cell Mol Genet (1996) 0.89
Hudrolysis of butyryl derivatives of adenosine cyclic 3':5'-monophosphate by Chinese hamster ovary cell extracts and characterization fo the products. J Biol Chem (1975) 0.89
Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26). Am J Hum Genet (1991) 0.89
Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res (1993) 0.89
An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat Res (1994) 0.88
HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. Carcinogenesis (1993) 0.87
Diversity of rheumatoid synovial tissue T cells by T cell receptor analysis. Oligoclonal expansion in interleukin-2-responsive cells. Arthritis Rheum (1991) 0.87
Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT) Mutagenesis (1990) 0.87
Induction and expression of mutations in mammalian cells in the absence of DNA synthesis and cell division. Mutat Res (1982) 0.87
Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes. Mutat Res (1988) 0.86
Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res (1999) 0.86
The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status. Mutat Res (2001) 0.86
Markers for carcinogenicity among butadiene-polymer workers in China. Chem Biol Interact (2001) 0.86
HPRT mutations in vivo in human CD 34+ hematopoietic stem cells. Mutat Res (1999) 0.85
V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat Res (1992) 0.85
Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients. Cancer Immunol Immunother (1991) 0.85
hprt mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology (1996) 0.85
HLA loss variants of a B27+ lymphoblastoid cell line: genetic and cellular characterization. Hum Immunol (1984) 0.84
Southern-blot analyses of human T-lymphocyte mutants induced in vitro by gamma-irradiation. Mutat Res (1990) 0.84
Quantification and analysis of reverse mutations at the hgprt locus in Chinese hamster ovary cells. Mutat Res (1982) 0.84
Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res (1995) 0.84
Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys). Environ Mol Mutagen (1991) 0.84
Increased frequency of specific genomic deletions resulting from in vitro malathion exposure. Cancer Res (1996) 0.83
DNA loop domains in a 1.4-Mb region around the human hprt gene mapped by cleavage mediated by nuclear matrix-associated topoisomerase II. Mol Gen Genet (1998) 0.82
Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes. Mutat Res (1986) 0.82
Fluctuation analyses of spontaneous mutations to 6-thioguanine resistance in Chinese hamster ovary cells in culture. Mutat Res (1981) 0.82
A guide for the performance of the Chinese hamster ovary cell/hypoxanthine-guanine phosphoribosyl transferase gene mutation assay. Mutat Res (1987) 0.82
Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environ Mol Mutagen (1995) 0.82
Development of long PCR techniques to analyze deletion mutations of the human hprt gene. Mutat Res (1998) 0.82
The effect of T-lymphocyte 'clonality' on the calculated hprt mutation frequency occurring in vivo in humans. Mutat Res (1994) 0.82
Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions. Cancer Res (2001) 0.81
Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations. Environ Mol Mutagen (2002) 0.81
X-ray induction of 6-thioguanine-resistant mutants in division arrested, G0/G1 phase Chinese hamster ovary cells. Mutat Res (1985) 0.81
Hypoxanthine-guanine phosphoribosyltransferase deficiency: biochemical and molecular findings in six Argentine patients. Nucleosides Nucleotides Nucleic Acids (2007) 0.81
Phenotypic expression time of mutagen-induced 6-thioguanine resistance in Chinese hamster ovary cells (CHO/HGPRT system): expression in division-arrested cell cultures. Environ Mutagen (1982) 0.81
Genetic instability in human T-lymphocytes. Mutat Res (1998) 0.81
Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer. Cancer Res (1991) 0.81
Mutagenicity, cytotoxicity, and DNA binding of platinum(II)-chloroammines in Chinese hamster ovary cells. Cancer Res (1980) 0.81
Molecular analyses of a Lesch-Nyhan syndrome mutation (hprtMontreal) by use of T-lymphocyte cultures. Hum Genet (1990) 0.81
Effect of folate deficiency on mutations at the hprt locus in Chinese hamster ovary cells exposed to monofunctional alkylating agents. Cancer Res (1997) 0.80
SCE induction is proportional to substitution in DNA for thymidine by CldU and BrdU. Mutat Res (1983) 0.80
In vivo mutations in human blood cells: biomarkers for molecular epidemiology. Environ Health Perspect (1993) 0.80